Precision medicine - on target

Alternative splicing of proteins gives rise to an untapped wealth of tissue and disease-specific variants. Isoform Oncology is a new biotech exploiting isoform switching and alternative splicing for the development of new cancer biotherapeutics – designed to keep precision-medicine on target

Cancer is not solved. Patients need more. We are working for a future where “first-line” treatments work first time.
On target. On Time. Every Time.